PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 22, 2019Molecular Pharmaceutics145 citations

From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design

View Full Paper
MŠMiha ŠkaličBoehringer Ingelheim (Germany)DSDavide SabbadinParis Biotech SantéBSBoris SattarovParis Biotech Santé

Key Points

Key points are not available for this paper at this time.

Abstract

Chemical space is impractically large, and conventional structure-based virtual screening techniques cannot be used to simply search through the entire space to discover effective bioactive molecules. To address this shortcoming, we propose a generative adversarial network to generate, rather than search, diverse three-dimensional ligand shapes complementary to the pocket. Furthermore, we show that the generated molecule shapes can be decoded using a shape-captioning network into a sequence of SMILES enabling directly the structure-based de novo drug design. We evaluate the quality of the method by both structure- (docking) and ligand-based quantitative structure-activity relationship (QSAR) virtual screening methods. For both evaluation approaches, we observed enrichment compared to random sampling from initial chemical space of ZINC drug-like compounds.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Škalič et al. (2019) studied this question.

synapsesocial.com/papers/6a1ff71a35281a23f90db466https://doi.org/10.1021/acs.molpharmaceut.9b00634
Ask AI
Helpful
Bookmark
Share
View Full Paper